Your browser doesn't support javascript.
loading
Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
Erden, Abdulsamet; Ozdemir, Bahar; Karakas, Ozlem; Mutlu, Nevzat Mehmet; Izdes, Seval; Kalem, Ayse Kaya; Bilir, Yesim Aybar; Aypak, Adalet; Akinci, Esragul; Guner, Rahmet; Kucuksahin, Orhan.
Afiliação
  • Erden A; Division of Rheumatology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Ozdemir B; Division of Rheumatology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Karakas O; Division of Rheumatology, Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
  • Mutlu NM; Department of Anesthesiology and Reanimation-Critical Care, Ankara City Hospital, Ankara, Turkey.
  • Izdes S; Department of Anesthesiology and Reanimation-Critical Care, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey.
  • Kalem AK; Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey.
  • Bilir YA; Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Aypak A; Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
  • Akinci E; Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
  • Guner R; Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey.
  • Kucuksahin O; Department of Internal Medicine, Division of Rheumatology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey.
J Med Virol ; 93(3): 1532-1537, 2021 03.
Article em En | MEDLINE | ID: mdl-32860431

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia / Proteína Antagonista do Receptor de Interleucina 1 / Tratamento Farmacológico da COVID-19 Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia / Proteína Antagonista do Receptor de Interleucina 1 / Tratamento Farmacológico da COVID-19 Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia